ArticleBMC health services research2014

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece.

Charalampos Tzanetakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.